CEimpact Podcast

New guidelines suggest that for most asthma patients a single inhaler strategy with both an ICS and a quick onset LABA can be used for maintenance and rescue therapy. This has been shown to improve symptoms and decrease need for health care visits. But what is the latest data on SMART therapy and what are the barriers to its use? The GameChanger: SMART therapy should be the standard of care for mo...

In this episode, we tackle a whole range of issues – how to assess and meet our pharmacy residents and student pharmacists where they are, the challenges of maintaining guardrails while providing flexibility, and the responsibility we have as preceptors to stay abreast of best practices not only clinically, but as teachers and mentors so that we can make changes to our precepting practice when the...

40% of people experience vertigo in their lifetime. These simple questions help us know what's causing it and how to provide relief to patients through medications or triaging to the appropriate provider.   The GameChanger Migraine headaches can present as vertigo. Simple questions and recommendations from pharmacists can be lifechanging for these patients.   Guest Sarah Powell, MD Physician,...

Join us this episode as we discuss new recommendations from the American Dental Association on acute pain management.   The GameChanger Dosing acetaminophen and ibuprofen where they peak at the same time due to their synergistic properties, resulting in treatment being often more effective than hydrocodone-apap and oxycodone-apap for pain relief.   Guest Karen Baker, M.S.Pharm., R.Ph Associate Pro...

Shortages, access, and cost have led to compounding GLP1s, which has created confusion and misinformation for patients and healthcare providers. Join us as we discuss this practice and delve into what you need to know as a healthcare provider. THE GAMECHANGER: The advent of GLP1s is a true GameChanger in the health of patients with diabetes, cardiovascular diseases, and obesity, and has led to acc...

This episode discusses the 2023 Inflation Reduction Act and HHS's authority to negotiate prices for high-cost drugs in Medicare Part D. In addition to the initial list of 10 drugs, HHS is now focused on medications used in the hospital and covered under Medicare Part B.   The GameChanger HHS updates the Inflation Reduction Act that will impact over 750, 000 people.   Host Geoff Wall, PharmD,...

This episode discusses quality and value in healthcare and how the BPCI program, designed to lower costs and enhance care quality, particularly in the post-acute phase, did not demonstrate notable positive impacts on HF-related measures. What does this mean for the larger health quality landscape?   The GameChanger Quality in healthcare is rapidly evolving. There are pressures at the population le...

The anti-rejection drug rapamycin has been shown in mice and other mammals to reverse cellular damage caused by aging to extend healthy life by up to 20%. This has caused massive off-label prescribing and use of rapamycin in humans as an anti-aging drug.   The GameChanger What do you tell patients about the evidence-based use of rapamycin for anti-aging?   Host Geoff Wall, PharmD, BCPS, FCCP, BCGP...

In this episode, we delve into the crucial topic of understanding generational differences in the context of pharmacy education. Our guest expert, Melissa Medina from the University of Oklahoma, brings a wealth of knowledge and experience to the table, shedding light on why grasping these generational nuances is paramount for preceptors working with pharmacy students and residents. Tune in to gain...

The GameChanger A new study looks at the utility of omalizumab in preventing food allergy reactions after accidental exposure.  ACEis and Beta-blockers should be avoided in patients with recurrent anaphylaxis if possible.   Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health   Reference Study: https://www.nej...

Stay updated on recently FDA-approved medications crucial for pharmacists. Gain essential insights on new drugs approved in the last 12 to 18 months, ensuring accurate dispensing and effective patient education.   The GameChanger SweatControl Patch approved for primary axillary hyperhidrosis. Update in treatment for Alzheimer's with mild cognitive impairment.   Host Joe Strain, PharmD Clinica...

The cardiometabolic syndrome is a concept recently developed by the American Heart Association to denote the totality of risk in a patient with risk factors that may lead to or worsen chronic kidney disease or cardiovascular events. A new validated scoring system has been endorsed by AHA to better assess the short and long-term risk for these in the general population.  We will discuss this scorin...

Several outbreaks of a relatively new, resistant fungal infection - candida auris - have been reported in the Pacific Northwest. It is highly contagious and its mortality has approached 60%. Listen in as we discuss what to watch for and how to prepare if this reaches your geography. THE GAMECHANGER:   Candida auris is resistant to most antifungals, has high plasticity, and its mortality approaches...

Do you feel like it is getting more difficult to engage your students or residents on your rotation and keep them engaged? Or maybe you personally feel a little bored with the same old activities and strategies. In this episode, preceptors Beth Cady and Carrie Vogler of Southern Illinois University Edwardsville on some creative strategies they use to engage their learners.   Kathy Schott, PhD Vice...

With pockets of measles outbreaks throughout the country, we discuss the reasons and strategize ways pharmacy can impact vaccination rates in their communities.   The GameChanger Measles was essentially eliminated from the US in 2000. Now, we are seeing a resurgence of outbreaks that have prompted the CDC to issue warnings and reminders of the importance of proper vaccination.   Geoff Wall, PharmD...

With record-cold temperatures in much of the United States this winter, a high number of cold injuries have been reported. This podcast discusses prevention and treatment for hypothermia and frostbite. Brrrrr! The GameChangers:   Frostbite prevention using layers and heating measures Hypothermia treatment using external and internal heating  Frostbite treatment with anticoagulants   Host Geoff Wal...

The American Diabetes Association has released the 2024 Standards of Care for people with Type 1 and Type 2 Diabetes. Join us as we talk with one of our favorite diabetes experts, Dr. Sue Cornell, about the major shifts in diabetes care that are omnipresent in this year's guideline updates.   The GameChanger Diabetes treatment is shifting to prevention and delay. After a long period of time w...

Insulin icodec is the first class of long-acting insulin to be administered only once a week. Join host, Jen Moulton, as she discusses the safety and efficacy of insulin icodec with guest, Geoff Wall. The GameChanger Insulin icodec is the first of the ultra long-acting insulins with once weekly dosing. Multiple clinical studies have suggested these pharmacokinetics work. A new meta-analysis sugges...

Alcohol Use Disorder (AUD) and cirrhosis are common medical conditions with significant morbidity and mortality. Join host, Geoff Wall, as he evaluates the new  American College of Gastroenterology guidelines.   The GameChanger The MELD score is now preferred over the Madrey score for assessing mortality. Baclofen is the primary treatment for reducing consumption and craving in alcohol use disorde...

Communication is ‘an essential duty’ of a pharmacist and the cornerstone of quality patient care. And yet, it continues to be one of the most common frustrations reported by preceptors when working with students and residents. Many factors may be at play, including a pandemic, as well as a digital society where so much communication happens in quick, abbreviated bytes. On this episode, guest Chris...

Hyponatremia is a side effect of most diuretics but the incidence from thiazides is unknown. Join host, Geoff Wall, as he evaluates a new study from Denmark evaluating hyponatremia and thiazides.   The GameChanger Thiazide diuretics are considered first-line therapy but electrolyte side effects are underevaluated. A new study suggests hyponatremia is significantly more common than previously repor...

Sickle cell disease (SCD) is a devastating medical condition causing pain, fatigue, and early mortality. Join host, Geoff Wall, as he evaluates a new gene therapy via CRISPR that may cure SCD.   The GameChanger CRISPR is a new method to develop targeted gene editing treatments. Lovo-cel is the first FDA-approved therapy and may treat sickle cell disease (SCD) - for only $2 million.   Host Geoff Wa...

Atrial fibrillation is the most common clinical arrhythmia. The newest guidelines have significant changes in diagnosis, assessment, and treatment. Join host, Geoff Wall, with guest Matt Boyd, as they evaluate the pharmacotherapy changes in the new guidelines in this two-part episode. The GameChanger Rate and rhythm control medications largely have the same clinical outcomes. Patients with heart f...

Atrial fibrillation is the most common clinical arrhythmia. The newest guidelines have significant changes in diagnosis, assessment, and treatment. Join host, Geoff Wall, as he evaluates the first half of the guidelines in this two-part episode. The GameChanger Different stratifying types of atrial fibrillation no longer exist. Additionally, left atrial occlusive devices are now recommended as fir...

Utter the words "Artificial Intelligence" to other preceptors and pharmacy faculty, and you might get a reaction that ranges anywhere from fear and anxiety to excitement. In this insightful discussion, we explore the fundamental question of what AI is and its diverse application in shaping the landscape of pharmacy education. Guest Tim Aungst delves into the challenges surrounding studen...